Clostridium butyricum live bacteria powder
Function and Efficacy
This product is a live Clostridium butyricum (spore) preparation, which can tolerate gastric acid entering the intestine, secrete butyric acid (butyric acid), an important nutrient for intestinal mucosal regeneration and repair, repair damaged intestinal mucosa, eliminate inflammation, and nourish the intestine. It can also promote the growth of beneficial intestinal bacteria such as Bifidobacterium, inhibit the growth of harmful intestinal bacteria such as Shigella dysenteriae, restore the balance of intestinal flora, reduce the production of intestinal toxins such as amines, ammonia, and indoles, and their toxicity to intestinal mucosa, and restore intestinal immune function and normal physiological function. This product has a significant therapeutic effect on rat immune ulcerative colitis, inhibits the excessive and abnormal expression of inflammatory factors such as IL-8 and TNF-α, inhibits the excessive expression of anti-colon antibody IgG, reduces the transformation rate of B lymphocytes, increases the transformation rate of T lymphocytes, corrects intestinal immune disorders, restores intestinal immune tolerance, eliminates inflammation and ulcers, and effectively treats ulcerative colitis. At the same time, Clostridium butyricum produces enzymes and vitamins in the intestine to promote the digestion and absorption of nutrients.
Ingredients
Each bag of this product contains no less than 7.5×106 (6 is a superscript) CFU of Clostridium butyricum. The auxiliary material is glucose.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| GLUCOSEExcipients |
This product is a live Clostridium butyricum (spore) preparation, which can tolerate gastric acid entering the intestine, secrete butyric acid (butyric acid), an important nutrient for intestinal mucosal regeneration and repair, repair damaged intestinal mucosa, eliminate inflammation, and nourish the intestine. It can also promote the growth of beneficial intestinal bacteria such as Bifidobacterium, inhibit the growth of harmful intestinal bacteria such as Shigella dysenteriae, restore the balance of intestinal flora, reduce the production of intestinal toxins such as amines, ammonia, and indoles, and their toxicity to intestinal mucosa, and restore intestinal immune function and normal physiological function. This product has a significant therapeutic effect on rat immune ulcerative colitis, inhibits the excessive and abnormal expression of inflammatory factors such as IL-8 and TNF-α, inhibits the excessive expression of anti-colon antibody IgG, reduces the transformation rate of B lymphocytes, increases the transformation rate of T lymphocytes, corrects intestinal immune disorders, restores intestinal immune tolerance, eliminates inflammation and ulcers, and effectively treats ulcerative colitis. At the same time, Clostridium butyricum produces enzymes and vitamins in the intestine to promote the digestion and absorption of nutrients. More |
58367-01-4 | 15 |
Appearance
This product is a powder, the content is white or off-white powder, with gray-yellow spots, with a slightly special smell and sweet taste.
Indication
Various gastrointestinal symptoms caused by intestinal flora disorders and related acute and chronic diarrhea and indigestion, etc.
Usage and Dosage
Oral administration: Children, 1 bag at a time, 2-3 times a day, with warm water. For acute diarrhea, the course of treatment is 3-7 days; for chronic diarrhea, the course of treatment is 14-21 days.
Adverse Reactions
In previous clinical studies, no drug-related adverse reactions were observed.
Precautions
It is contraindicated for those with a history of allergy to microecological preparations.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
1 Clostridium butyricum is sensitive to ampicillin, cefazolin, cefuroxime, tetracycline, chloramphenicol, furazolidone (Furazolidone), co-trimoxazole and norfloxacin. Taking them at the same time with these antibacterial drugs can weaken their efficacy and should be taken separately (2-3 hours apart). 2 If used at the same time with other drugs, drug interactions may occur. Please consult a doctor or pharmacist for details.
Storage
Store in a dry place at room temperature.
Packaging Specification
Each bag contains 500 mg, and the number of viable Clostridium butyricum is not less than 1.5x107 (7 is a superscript) CFU/g
Validity Period
24 months
Manufacturer
Qingdao Eastsea Pharmaceutical Co., Ltd.
-
Founded in:
2003-08-08 -
Address:
No. 1377, Jiaozhouwan West Road, Huangdao District, Qingdao -
Tax NO.:
91370211750444874X -
Registered Funds:
60 million yuan -
Website:
-
Email: